Aperio Group’s MetLife MET Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $52.9M | Sell |
1,127,446
-33,675
| -3% | -$1.46M | 0.16% | 123 |
|
|
2020
Q3 | $43.2M | Buy |
1,161,121
+180,708
| +18% | +$6.86M | 0.15% | 137 |
|
|
2020
Q2 | $35.8M | Buy |
980,413
+245,782
| +33% | +$8.56M | 0.13% | 158 |
|
|
2020
Q1 | $22.5M | Sell |
734,631
-243,058
| -25% | -$10.8M | 0.1% | 209 |
|
|
2019
Q4 | $49.8M | Buy |
977,689
+238,011
| +32% | +$11.5M | 0.18% | 116 |
|
|
2019
Q3 | $34.9M | Buy |
739,678
+176,302
| +31% | +$8.41M | 0.14% | 167 |
|
|
2019
Q2 | $28M | Buy |
563,376
+58,966
| +12% | +$2.77M | 0.11% | 196 |
|
|
2019
Q1 | $21.5M | Buy |
504,410
+20,277
| +4% | +$897K | 0.09% | 246 |
|
|
2018
Q4 | $19.9M | Sell |
484,133
-15,431
| -3% | -$662K | 0.1% | 234 |
|
|
2018
Q3 | $23.3M | Sell |
499,564
-22,104
| -4% | -$1.01M | 0.1% | 219 |
|
|
2018
Q2 | $22.7M | Buy |
521,668
+28,337
| +6% | +$1.32M | 0.11% | 207 |
|
|
2018
Q1 | $22.6M | Sell |
493,331
-10,287
| -2% | -$499K | 0.11% | 211 |
|
|
2017
Q4 | $25.5M | Buy |
503,618
+20,226
| +4% | +$1.07M | 0.13% | 183 |
|
|
2017
Q3 | $25.1M | Sell |
483,392
-55,666
| -10% | -$2.71M | 0.14% | 166 |
|
|
2017
Q2 | $26.4M | Buy |
539,058
+19,927
| +4% | +$924K | 0.16% | 144 |
|
|
2017
Q1 | $24.4M | Sell |
519,131
-49,655
| -9% | -$2.37M | 0.17% | 137 |
|
|
2016
Q4 | $27.3M | Buy |
568,786
+48,048
| +9% | +$2.2M | 0.21% | 104 |
|
|
2016
Q3 | $20.6M | Buy |
520,738
+54,640
| +12% | +$2.05M | 0.15% | 155 |
|
|
2016
Q2 | $16.5M | Buy |
466,098
+69,248
| +17% | +$2.7M | 0.13% | 182 |
|
|
2016
Q1 | $15.5M | Sell |
396,850
-2,190
| -0.5% | -$81.9K | 0.13% | 176 |
|
|
2015
Q4 | $17.1M | Buy |
399,040
+925
| +0.2% | +$40.7K | 0.16% | 160 |
|
|
2015
Q3 | $16.7M | Buy |
398,115
+41,120
| +12% | +$1.92M | 0.17% | 138 |
|
|
2015
Q2 | $17.8M | Buy |
356,995
+46,373
| +15% | +$2.2M | 0.18% | 132 |
|
|
2015
Q1 | $14M | Buy |
310,622
+18,165
| +6% | +$816K | 0.16% | 154 |
|
|
2014
Q4 | $14.1M | Sell |
292,457
-1,119
| -0.4% | -$53.2K | 0.17% | 137 |
|
|
2014
Q3 | $14.1M | Buy |
293,576
+28,583
| +11% | +$1.39M | 0.19% | 134 |
|
|
2014
Q2 | $13.1M | Buy |
264,993
+14,005
| +6% | +$655K | 0.19% | 130 |
|
|
2014
Q1 | $11.8M | Buy |
+250,988
| New | +$11.5M | 0.17% | 138 |
|
|
2013
Q4 | – | Sell |
-208,070
| Closed | -$9.33M | – | 127 |
|
|
2013
Q3 | $8.71M | Buy |
208,070
+30,790
| +17% | +$1.33M | 0.17% | 134 |
|
|
2013
Q2 | $7.23M | Buy |
+177,280
| New | +$6.52M | 0.17% | 130 |
|
Other funds holding MET
Aperio Group's MET Position: Q4 2020 in Review
Aperio Group reduced its MetLife (MET) stake by 2.9% in Q4 2020, selling an estimated $1.46M and leaving 1,127,446 shares worth $52.9M. The position accounts for 0.16% of the portfolio, ranked #123.
Aperio Group first reported a position in MET in Q2 2013 and has held it in 30 quarters since. 1,046 funds tracked by Wall St. Rank hold MET as of Q4 2020.
- Aperio Group held 1,127,446 shares of MetLife worth $52.9M as of Q4 2020.
- Aperio Group sold 33,675 MetLife shares in Q4 2020, an estimated $1.46M.
- MetLife made up 0.16% of Aperio Group's portfolio in Q4 2020, its #123 holding.
- Aperio Group first reported a position in MetLife in Q2 2013 and has held it in 30 quarters since.
- 1,046 funds tracked by Wall St. Rank held MetLife as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.